Federal Register / Vol. 65, No. 114 / Tuesday, June 13, 2000 / Notices 37139

demonstration activities; developing

continuing education and distancebased training; and developing

leadership and training opportunities.

B. Eligible Applicant

Assistance will be provided only to

ASTDHPPHE. No other applications

will be solicited. ASTDHPPHE is the

only appropriate and qualified agency

that can provide the services specified

under this announcement.

Eligibility is limited to ASTDHPPHE

because of its unique relationship with

the Association of State and Territorial

Health Officials (ASTHO) and other

ASTHO affiliates. ASTDHPPHE is the

only national, nonprofit health

education organization of which

program directors and staff representing

all States and territories are members.

As such, it is uniquely capable, and

organized specifically to serve as a

leader and a conferee of activities

relative to State Health education

programs. ASTHO represents the chief

public health official of each State and

territory. Through its own membership,

ASTHO has developed unique

knowledge and understanding of the

needs and operations of State Health

agencies.

ASTDHPPHE is the only affiliate

whose primary mission is to promote

health education and health promotion

as core disciplines of public health

practice and to advocate for quality

health education and health promotion

programs and strategies to address the

nation’s leading health problems.

ASTDHPPHE has served as a health

education and health promotion policy

development and capacity building

organization since 1946, and over the

years it has strengthened public health

education goals and objectives. The

membership is uniquely diverse and its

members, who provide major leadership

to State and Territorial categorical

health areas, have strengthened health

education and health promotion

programs nationwide. ASTDHPPHE also

provides consultation and technical

assistance to numerous agencies and has

liaison relationships with many national

organizations. In this way, the

Association is deeply involved in health

education and health promotion

program development and evaluation

efforts that are conducted nationally.

In collaboration with other national

organizations, the association

accomplishes its mission by

disseminating information on state-ofthe-art health education and health

promotion policies and strategies. The

association has the established

relationships and expertise necessary to

carry-out this cooperative agreement.

The unique information exchange

among the ASTDHPPHE members and

expert program knowledge provide it

with special credibility with national,

private, and voluntary agencies. In

addition, for the last 16 years

ASTDHPPHE has worked with National

Center for Chronic Disease Prevention

and Health Promotion in co-sponsoring

the annual Health education and Health

promotion conference. Although other

organizations may possess some of these

abilities and/or perform some of these

roles, no other organization has

ASTDHPPHE’s unique characteristics.

ASTDPPHE is comprised of State health

promotion/health education program

directors, who are necessary to

effectively carry out the activities

entailed in this program.

Note: Public Law 104–65 states that an

organization described in selection 501(c)(4)

of the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $735,000 is available

in FY 2000 to fund this award. It is

expected that the award will begin on or

about September 30, 2000, and will be

for a 12-month budget period within a

project period of up to five years. This

funding estimate may change.

Continuation awards within an

approved project period will be made

on the basis of satisfactory progress as

evidenced by required reports and

availability of funds.

D. Where To Obtain Additional

Information

This and other CDC announcements

can be found on the CDC home page

internet address: http://www.cdc.gov. If

you have questions business

management technical assistance may

be obtained from:

Barry Copeland, Grants Management

Specialist, Grants Management

Branch, Procurement and Grants

Office, Centers for Disease Control

and Prevention, Room 300, 2920

Brandywine Road, Atlanta, Georgia

30341, Telephone: 770/488–2762, Email address: bjc8@CDC.gov

For technical assistance, contact:

John M. Korn, Public Health Advisor,

National Center for Chronic Disease

Prevention and Health Promotion,

Centers for Disease Control and

Prevention (CDC), 4770 Buford

Highway NE, Mailstop K–30, Atlanta,

GA 30341–3717, Telephone: 770/488–

5427, E-mail address: jmk3@cdc.gov

Dated: June 6, 2000.

Henry S. Cassel, III,

Deputy Director, Procurement and Grants

Office,, Center for Disease Control and

Prevention (CDC).

[FR Doc. 00–14828 Filed 6–12–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 00010]

Asthma Surveillance and Interventions

in Hospital Emergency Departments;

Notice of Availability of Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 2000

funds for a cooperative agreement

program for asthma surveillance and

interventions in hospital emergency

departments. CDC is committed to

achieving the health promotion and

disease prevention objectives of

‘‘Healthy People 2010,’’ a national

activity to reduce morbidity and

mortality and improve the quality of

life. This announcement is related to the

focus areas of Environmental Health and

Respiratory Diseases. For the conference

copy of ‘‘Healthy People 2010,’’ visit the

internet site: <http://www.health.gov/

healthypeople>.

The purpose of this program is to

implement and evaluate a sentinel

surveillance system designed to monitor

trends in and identify reasons for

receiving asthma care in hospital

emergency departments; and to develop

and implement interventions to improve

asthma care and to use the surveillance

data to evaluate these interventions.

B. Eligible Applicants

Applications may be submitted by

public and private nonprofit

organizations; that is, universities,

colleges and medical schools affiliated

with non-profit hospitals. No other

applications are solicited. Universities

affiliated with nonprofit hospitals are

targeted because they have research

expertise and can coordinate with

several hospitals emergency

departments which will identify asthma

patients, enroll them in interventions,

and collect and analyze data.

Universities are likely to have existing

relationships with departments of

health and can coordinate surveillance

and intervention activities.

Note: Public Law 104–65 states that an

organization described in section 501(c)(4) of

37140 Federal Register / Vol. 65, No. 114 / Tuesday, June 13, 2000 / Notices

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan or any other form.

C. Availability of Funds

Approximately $500,000 is available

in FY 2000 to fund approximately two

awards. It is expected that the average

award will be up to $250,000 per year

for a three-year period. It is expected

that the awards will begin on or about

September 30, 2000, and will be made

for a 12-month budget period within a

project period of up to three years.

Funding estimates may change.

Continuation awards within an

approved project period will be made

on the basis of satisfactory progress as

evidenced by required reports and the

availability of funds.

Use of Funds

The budget should include a request

for travel funds for appropriate key staff

to participate in the recipient planning

meeting in Atlanta.

D. Program Requirements

In conducting activities to achieve the

purpose of this cooperative agreement,

the recipient will be responsible for the

activities under 1. (Recipient Activities)

and CDC will be responsible for the

activities under 2. (CDC Activities).

1. Recipient Activities

a. Collaborate with the State health

department and a total of three to four

emergency departments (EDs) in

locations serving diverse populations

(e.g., rural, urban and suburban) to plan

and implement surveillance and model

interventions for asthma.

b. Participate in a recipient meeting to

coordinate surveillance and

intervention activities across sites.

c. Develop and pilot test all data

collection instruments.

d. Develop model interventions to

reduce severe asthma exacerbations by

improving care for asthma.

e. Analyze the data and report

surveillance findings to collaborating

EDs, the State health department and

CDC, make presentations and prepare

written manuscripts for publications.

f. Evaluate the surveillance system

and the effectiveness of the

interventions to reduce severe asthma

exacerbations.

2. CDC Activities

a. Provide technical assistance in all

stages of the project.

b. Facilitate communication/

coordination among recipients to

improve efficiency of activities, quality

of surveillance data, and effectiveness of

interventions.

c. The CDC IRB will review and

approve the protocol initially and on at

least an annual basis until the research

project is completed.

E. Application Content

Use the information in the Program

Requirements, Other Requirements, and

Evaluation Criteria sections to develop

the application content. Your

application will be evaluated on the

criteria listed, so it is important to

follow them in laying out your program

plan. The narrative should not exceed

30 double-spaced pages, printed on one

side, with one inch margins, and

unreduced font. The applications must

be submitted unstapled and unbound.

Applications for the cooperative

agreements should include:

1. Background and Need

a. Description of the number of

asthma cases, hospitalizations, deaths

and/or prevalence in the State.

b. Description of how hospital

emergency department surveillance will

be used to develop model interventions

to improve medical and environmental

management of asthma which can result

in decreased asthma exacerbations.

c. Description of the applicant’s

collaborations with other hospitals,

hospital emergency departments, health

departments and organizations in

conducting research or surveillance or

developing interventions to reduce

morbidity or mortality.

d. Description of collaborating

hospital emergency departments’

experience in public health initiatives,

surveillance projects, research and

multi-center studies, including

interventions.

e. Description of the health

department’s experience working with

hospital emergency departments or

hospitals and relevant asthma

prevention surveillance and prevention

activities.

2. Goals and Objectives

Description of specific, measurable

and time-framed goals and objectives

that are consistent with the proposed

theme, purpose and objectives.

3. Methods

a. Description of proposed activities

to meet the stated goals and objectives.

For example, describe how

interventions will be developed to meet

the needs of the population served.

b. Description of timeline to measure

progress in meeting stated goals and

objectives.

c. Description of the type of hospital

(e.g., private, public, etc.) and the basis

for selection of collaborating hospitals

(e.g., inner city, urban, suburban and

rural) for each participating ED.

d. Description of the experience of

principal investigators, collaborating ED

contacts, and health department

contacts in:

(1) designing, implementing,

administering and evaluating

surveillance and interventions,

(2) prior publications, and

(3) specific authority to carry out the

proposed surveillance and

interventions.

e. Include letters of support for each

collaborating ED and the health

department.

f. Description of the roles of all staff

involved in the project for each

participating ED and the health

department regardless of their funding

source. Include their title,

qualifications, experience, percentage of

time each will devote to the project, as

well as that portion of their salary to be

paid by the grant.

g. Description of the logistics and

personnel involved in data collection,

reporting, analysis, evaluation,

dissemination of results and

publication.

h. Description of how applicant will

meet the CDC policy requirements

regarding the inclusion of women,

ethnic and racial groups in the

surveillance and interventions. This

includes:

(1) The proposed plan for the

inclusion of both sexes and racial and

ethnic minority populations for

appropriate representation.

(2) The proposed justification when

representation is limited or absent.

(3) A statement as to whether the

design of the surveillance and

interventions is adequate to measure

differences when warranted.

(4) A statement as to whether the

plans for recruitment and outreach for

participants include the process of

establishing partnerships with

community(ies) and recognition of

mutual benefits.

i. Description of how surveillance

findings will be shared to reduce the

burden of asthma. EDs may use the

findings to develop hospital policies,

and health departments may develop

community interventions.

j. Description of the planned

interventions and how their

effectiveness will be evaluated.

4. Evaluation

a. Description of a detailed plan to

document progress, effectiveness,

impact and outcome.

b. Description of the ability of staff to

perform the evaluation.

Federal Register / Vol. 65, No. 114 / Tuesday, June 13, 2000 / Notices 37141

c. Description of how evaluation

findings will be used to improve the

surveillance and interventions.

5. Budget Justification

Description of first year budget with

future annual projections.

6. Human Subjects

Description of how human subjects

will be involved and how they will be

protected.

F. Submission and Deadline

Letter of Intent (LOI)

Your letter of intent should include a

brief description of surveillance and

interventions planned, the populations

served by the participating hospital

emergency departments, and State

health department asthma prevention

and surveillance activities.

The letter of intent must be submitted

on or before July 10, 2000 to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

Application

Submit the original and five copies of

PHS–398 (OMB Number 0925–0001).

Forms are in the application kit. On or

before August 10, 2000, submit the

application to the Grants Management

Specialist identified in the ‘‘Where to

Obtain Additional Information’’ section

of this announcement.

Deadline: Applications shall be

considered as meeting the deadline if

they are either:

(a) Received on or before the deadline

date; or

(b) Sent on or before the deadline date

and received in time for submission to

the independent review group.

(Applicants must request a legibly dated

U.S. Postal Service postmark or obtain

a legibly dated receipt from a

commercial carrier or U.S. Postal

Service. Private metered postmarks shall

not be acceptable as proof of timely

mailing.)

Late Applications: Applications

which do not meet the criteria in (a) or

(b) above are considered late

applications, will not be considered,

and will be returned to the applicant.

G. Evaluation Criteria

Each application will be evaluated

individually against the following

criteria by an independent review group

appointed by CDC.

1. Background and Need (20 Points)

a. The extent to which the applicant

presents data justifying the need for

asthma surveillance and interventions

in terms of magnitude of the asthma

problem in their area.

b. The extent to which applicant

describes how hospital emergencybased surveillance for asthma will be

used to develop and evaluate

interventions in EDs serving different

populations (e.g., inner city, urban,

suburban, rural).

c. The extent to which the applicant

describes current and previous

experiences conducting surveillance,

research and/or interventions in

hospital emergency departments.

d. The extent to which applicant

describes collaborating EDs’ past

experiences working with the State

health department and past

surveillance, research and/or

intervention activities.

e. The extent to which applicant

describes the State health department’s

experience collaborating with hospitals

and hospital emergency departments as

well as asthma surveillance and

prevention activities.

2. Goals and Objectives (15 Points)

The extent to which the applicant has

included goals which are relevant to the

purpose of the application and feasible

to be accomplished during the project

period, and the extent to which these

are specific and measurable.

3. Methods (50 Points)

a. The extent to which the applicant

provides a detailed description of

proposed activities which are likely to

achieve each objective and overall

program goals including designation of

responsibility for each action

undertaken.

b. The extent to which applicant

provides a reasonable and complete

schedule for implementing all activities.

c. The extent to which applicant

describes the different populations

served by collaborating hospital EDs

and demonstrates support from a

contact person within each

collaborating ED who will serve as

coordinator for the project.

d. The extent to which position

descriptions, resumes and lines of

command are appropriate for

accomplishment of program goals and

objectives.

e. The extent to which concurrence

with the applicant’s plans by all other

involved parties is specific and

documented, especially with regard to

data collection, analysis, dissemination,

development; implementation of

interventions; and evaluation of

surveillance and interventions.

f. The degree to which the applicant

has met the CDC Policy requirements

regarding the inclusion of women,

ethnic, and racial groups in the

proposed activities. This includes:

(1) The proposed plan for the

inclusion of both sexes and racial and

ethnic minority populations for

appropriate representation.

(2) The proposed justification when

representation is limited or absent.

(3) A statement as to whether the

design of the study is adequate to

measure differences when warranted.

(4) A statement as to whether the

plans for recruitment and outreach for

study participants include the process

of establishing partnerships with

communities and recognition of mutual

benefits.

g. The extent to which applicant

describes how surveillance findings will

be shared and used to develop

interventions and policies to reduce the

burden of acute asthma exacerbations.

h. The extent to which applicant

describes the types of interventions,

including provisions for continuity of

medical care, tailoring interventions to

different populations, and the

evaluation.

i. The extent to which applicant

demonstrates a willingness to

collaborate with other recipients.

4. Evaluation (15 points)

a. The extent to which the proposed

evaluation system is detailed and will

document program progress,

effectiveness, impact and outcome.

b. The extent to which applicant

documents staff availability, expertise

and capacity to perform the evaluation.

c. The extent to which a feasible plan

for reporting evaluation results and

using evaluation information for

programmatic decisions is included.

5. Budget and Justification (not scored)

The extent to which the budget is

reasonable, adequately justified and

consistent with the intended use of

grant funds.

6. Human Subjects (not scored)

Does the application adequately

address the requirements of Title 45

CFR Part 46 for the protection of human

subjects?

H. Other Requirements

Technical Reporting Requirements

Provide CDC with original plus two

copies of:

1. Semi-annual progress reports;

2. Financial status report, no more

than 90 days after the end of the budget

period; and

3. Final financial and performance

reports, no more than 90 days after the

end of the project period. Send all

reports to the Grants Management

37142 Federal Register / Vol. 65, No. 114 / Tuesday, June 13, 2000 / Notices

Specialist identified in the ‘‘Where to

Obtain Additional Information’’ section

of this announcement.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachment 1 in the

application kit.

AR–1—Human Subjects Requirements

AR–2—Requirements for Inclusion of

Women and Racial and Ethnic

Minorities in Research

AR–9—Paperwork Reduction Act

Requirements

AR–10—Smoke-Free Workplace

Requirements

AR–11—Healthy People 2010

AR–12—Lobbying Restrictions

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

section 301 of the Public Health Service

Act, [42 U.S.C. section 241], as

amended. The Catalog of Federal

Domestic Assistance number is 93.283.

J. Where To Obtain Additional

Information

This and other CDC announcements

are available through the CDC homepage

on the Internet at: http://www.cdc.gov.

To receive additional written

information and to request an

application kit, call 1–888–GRANTS4

(1–888 472–6874). You will be asked to

leave your name and address and will

be instructed to identify the program

announcement number (00010).

If you have questions after reviewing

the contents of all the documents,

business management assistance may be

obtained from: Sonia Rowell, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Announcement 00010,

Centers for Disease Control and

Prevention, Room 3000, 2920

Brandywine Road, Atlanta, GA 30341–

4146, Telephone: (770) 488–2724, email

address: svp1@cdc.gov

For program technical assistance,

contact: Pamela Meyer, Epidemiologist,

Air Pollution and Respiratory Health

Branch, National Center for

Environmental Health, Centers for

Disease Control and Prevention, 1600

Clifton Road, NE, Mailstop E–17,

Atlanta GA 30333, telephone: (404)

639–2545, email address:

pmeyer@cdc.gov

Dated: June 7, 2000.

Henry S. Cassell III,

Acting Director, Procurement and Grants

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–14830 Filed 6–12–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 00097]

Uniform Population-Based Approach

to Case Ascertainment, Typology,

Surveillance, and Research on

Childhood Diabetes; Notice of

Availability of Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 2000

funds for a cooperative agreement

program to develop a multi-center and

uniform population-based approach to

case ascertainment, typology,

surveillance, and research on childhood

diabetes (diagnosis before the age of 20

years). This program addresses the

‘‘Healthy People 2010’’ focus area of

Diabetes. For the conference copy of

‘‘Healthy People 2010,’’ visit the

internet site: <http://

www.healthypeople>. In view of the

importance of racial and ethnic health

disparity issues, the purpose of the

program is to use a uniform multi-center

approach in diverse populations for

multiple purposes:

1. Using existing data of known

prevalent cases of childhood diabetes,

develop a uniform typology of the

prevalent cases, obtain type-specific

prevalence estimates, and describe

characteristics of the different types of

childhood diabetes;

2. Based on the extensive collection of

new cases of childhood diabetes,

develop a uniform typology of the

incident cases, obtain accurate and

precise population-based estimates of

the type-specific incidence and secular

trends of new cases, and describe the

characteristics of the different types of

childhood diabetes;

3. Develop a uniform approach to

follow incident cases of childhood

diabetes to ascertain changes in

typology, characteristics and outcomes,

and to maintain a ‘‘pool’’ of incident

cases of childhood diabetes.

Characterization of types of childhood

diabetes should include a description of

potential risk factors (including family

history, maternal diabetes, race/

ethnicity, sex, weight and height, birthweight, etc), other characteristics

(including presence of acanthosis

nigricans, symptoms and circumstances

at or preceding diagnosis, treatment and

response to treatment, HbA1c, lipids,

and blood pressure levels, etc), potential

laboratory measurements (C-peptide and

insulin levels, immunological markers,

etc), potential complications (including

microalbuminuria, hypertension,

retinopathy, neuropathy, infections,

etc), and quality of medical care

(including screening frequencies for

HbA1c, lipid profiles,

microalbuminuria, retinal and foot

examinations, blood pressure checks,

nutrition counseling, rates of

hospitalization for complications, etc).

This collaborative program will

consist of two phases. Phase I (12

months)—Planning, developing

networks of care providers and other

partnerships, and collaboration on the

development of the protocol and

Institutional Review Board clearances.

Phase II (48 months)—Data collection,

monitoring, analyzes, and collaborative

reporting of the results, on a yearly

basis.

B. Eligible Applicants

Applications may be submitted by

public and private nonprofit

organizations and by governments and

their agencies; that is, universities,

colleges, research institutions, hospitals,

other public and private nonprofit

organizations, State and local

governments or their bona fide agents,

and federally recognized Indian tribal

governments, Indian tribes, or Indian

tribal organizations.

Note: Public Law 104–65 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $500,000 is available

in FY 2000 to fund approximately 2 to

3 awards. It is expected that the average

award will be $200,000 ranging from

$150,000 to $250,000. It is anticipated

that additional funds may be available

in FY 2001–2004 to increase the average

award to approximately $500,000 in

Years 2–5, ranging from $400,000 to

$600,000. It is expected that the awards

will begin on or about September 30,

2000, and will be made for a 12-month

budget period within a project period of

up to 5 years.